Loading...
Human papillomavirus (HPV) vaccination is recommended for girls and young women (age range, 9–26), but acceptance of this primary prevention strategy continues to be slow. Studying HPV immunization patterns may help identify barriers to use. In two studies, investigators have explored HPV vaccination rates in women with diagnoses of cervical intraepithelial neoplasia (CIN), and the relation between vaccine uptake and sexual behavior in adolescent and young-adult women.
In one study, investigators in Connecticut used surveillance registry data and interviews to assess HPV vaccination status in 269 adolescents and young women (age, ≤27) with diagnoses of CIN ≥2 or adenocarcinoma in situ. In all, 43% of respondents reported having received at l…